Literature DB >> 2337625

Regulation of the corpus luteum by protein kinase C. II. Inhibition of lipoprotein-stimulated steroidogenesis by prostaglandin F2 alpha.

M C Wiltbank1, M G Diskin, J A Flores, G D Niswender.   

Abstract

This study was designed to examine the antisteroidogenic action of prostaglandin (PG) F2 alpha on ovine luteal cells in vitro. Purified populations of large and small steroidogenic luteal cells were treated with lipoproteins, luteinizing hormone (LH), and/or PGF2 alpha. To investigate the involvement of the protein kinase C (PKC) pathway in hormone action, luteal cells were made PKC-deficient by treatment for 12 h with 1 microM phorbol-12-myristate-13-acetate. Progesterone production by nonstimulated large and LH-stimulated small luteal cells was significantly increased by treatment with high- and low-density lipoprotein (HDL, 5-fold increase; LDL, 2-fold increase). PGF2 alpha inhibited (p less than 0.0001) progesterone production by HDL-stimulated large luteal cells in a dose-dependent manner, with 60 nM causing maximal inhibition. No effect of PGF2 alpha (20nM-20 microM) was found on production of progesterone by HDL-stimulated, PKC-deficient large cells or by LH- and HDL-stimulated small luteal cells. These results suggest that PGF2 alpha has a direct antisteroidogenic effect on the large luteal cell that is mediated through the PKC second messenger pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337625     DOI: 10.1095/biolreprod42.2.239

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  9 in total

1.  Gonadotropin- and lipoprotein-supported progesterone production by primate luteal cell types in culture.

Authors:  S L Sanders; R L Stouffer
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  Effect of decreasing intraluteal progesterone on sensitivity of the early porcine corpus luteum to the luteolytic actions of prostaglandin F2alpha.

Authors:  Francisco J Diaz; Wenxiang Luo; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

3.  Comparison of mRNA levels for the PGF(2α) receptor (FP) during luteolysis and early pregnancy in the ovine corpus luteum.

Authors:  B R Rueda; I W Botros; K L Pierce; J W Regan; P B Hoyer
Journal:  Endocrine       Date:  1995-11       Impact factor: 3.633

4.  Steady-state concentrations of mRNA encoding the receptor for luteinizing hormone during the estrous cycle and following prostaglandin F(2α) treatment of ewes.

Authors:  M K Guy; J L Juengel; T R Tandeski; G D Niswender
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

Review 5.  History, insights, and future perspectives on studies into luteal function in cattle.

Authors:  Cecily V Bishop; Vimal Selvaraj; David H Townson; Joy L Pate; Milo C Wiltbank
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

6.  Comparison of endocrine and cellular mechanisms regulating the corpus luteum of primates and ruminants.

Authors:  M C Wiltbank; S M Salih; M O Atli; W Luo; C L Bormann; J S Ottobre; C M Vezina; V Mehta; F J Diaz; S J Tsai; R Sartori
Journal:  Anim Reprod       Date:  2012-07       Impact factor: 1.807

7.  Concentration of mRNA encoding 3 beta-hydroxysteroid dehydrogenase/delta 5,delta 4 isomerase (3 beta-HSD) and 3 beta-HSD enzyme activity following treatment of ewes with prostaglandin F2 alpha.

Authors:  J L Juengel; B M Meberg; E W McIntush; M F Smith; G D Niswender
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

8.  Stepwise activation of the gonadotropic signal transduction pathway, and the ability of prostaglandin F2alpha to inhibit this activated pathway.

Authors:  J E Väänänen; S Lee; C C Väänänen; B H Yuen; P C Leung
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

9.  Profiling of luteal transcriptome during prostaglandin F2-alpha treatment in buffalo cows: analysis of signaling pathways associated with luteolysis.

Authors:  Kunal B Shah; Sudeshna Tripathy; Hepziba Suganthi; Medhamurthy Rudraiah
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.